Viewing Study NCT00335595


Ignite Creation Date: 2025-12-24 @ 1:49 PM
Ignite Modification Date: 2026-01-17 @ 8:37 PM
Study NCT ID: NCT00335595
Status: COMPLETED
Last Update Posted: 2013-02-20
First Post: 2006-06-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Bevacizumab Alone or Combined With Capecitabine and Oxaliplatin as Support Therapy in Metastatic Colorectal Cancer Patients
Sponsor: Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: TTD-05-02
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View
None INDUSTRY View